Attention-Deficit/Hyperactivity Disorder (ADHD) is commonly perceived as a behavioral condition characterized by inattention, hyperactivity, and impulsivity.
ADHD is a neurological condition related to dopamine deficiency – a critical neurotransmitter guiding motivation, reward, and executive functioning. This deficit can manifest in several financial behaviors that are less about money and more about the brain's search for dopamine.
In my practice as a mental health professional, I frequently discuss various treatment options with individuals diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). One particular medication that has garnered attention in the mental health community is Wellbutrin, known generically as Bupropion.
This article was written by Dr. Adeel Sarwar. As a clinical psychologist, I am intrigued by the potential of AI in the field of mental health.
It has come to our attention that some individuals have mistakenly associated ADHDTest.ai (this website) with ADHDTesting.ai, an Australia-based company. We would like to emphasise that ADHDTest.ai and ADHDTesting.ai are separate entities, with no affiliation or connection between the two.
With current treatments being largely reliant on pharmaceuticals and behavioral therapy, there is a need for more innovative approaches that can help provide personalized treatment for those diagnosed with this disorder.
In the study Prevalence of Attention Deficit Hyperactivity Disorder in Primary School Children, conducted in Coimbatore, India, researchers found that ADHD prevalence was higher than the global estimate, at 11.32%. The highest prevalence was found at ages 9 and 10 (both with a rate of 26.4%).
